Victory Capital Management Portfolio holdings
AUM
$155B
1-Year Return
20.6%
This Quarter Return
-1.67%
1 Year Return
+20.6%
3 Year Return
+77.5%
5 Year Return
+161.59%
10 Year Return
+412.71%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.66B
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,919
New
146
Increased
1,494
Reduced
996
Closed
170
Top Buys
| 1 |
MKS Inc. Common Stock
MKSI
|
+$211M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$174M |
| 3 |
Ross Stores
ROST
|
+$142M |
| 4 |
Progressive
PGR
|
+$141M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$121M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.38B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$714M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$290M |
Sector Composition
| 1 | Technology | 16.92% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSL
2276
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $296K | ﹤0.01% |
49,713
+13,308
| +37% | +$79.2K |
|
|
ADAM
2277
Adamas Trust, Inc. Common Stock
ADAM
$654M
| $295K | ﹤0.01% |
22,896
+9,185
| +67% | +$118K |
|
2278
Cassava Sciences
SAVA
$104M
| $295K | ﹤0.01% |
14,128
+1,938
| +16% | +$40.5K |
|
|
SCPL
2279
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $294K | ﹤0.01% |
22,042
+7,401
| +51% | +$98.7K |
|
2280
Seneca Foods Class A
SENEA
$765M
| $293K | ﹤0.01% |
5,678
+54
| +1% | +$2.79K |
|
2281
Stoke Therapeutics
STOK
$1.31B
| $292K | ﹤0.01% |
20,224
-45,947
| -69% | -$663K |
|
|
DSKE
2282
DELISTED
Daseke, Inc. Common Stock
DSKE
| $291K | ﹤0.01% |
+34,701
| New | +$291K |
|
2283
Children's Place
PLCE
$162M
| $290K | ﹤0.01% |
6,263
+2,517
| +67% | +$117K |
|
2284
Beyond Meat
BYND
$199M
| $288K | ﹤0.01% |
7,803
+339
| +5% | +$12.5K |
|
2285
Advantage Solutions
ADV
$619M
| $287K | ﹤0.01% |
+57,087
| New | +$287K |
|
2286
Sleep Number
SNBR
$234M
| $287K | ﹤0.01% |
7,086
+3,088
| +77% | +$125K |
|
2287
Atlanticus Holdings
ATLC
$1.03B
| $286K | ﹤0.01% |
6,641
+909
| +16% | +$39.1K |
|
2288
Utz Brands
UTZ
$1.12B
| $286K | ﹤0.01% |
+20,286
| New | +$286K |
|
2289
Anika Therapeutics
ANIK
$124M
| $285K | ﹤0.01% |
13,244
+3,805
| +40% | +$81.9K |
|
2290
Hercules Capital
HTGC
$3.55B
| $285K | ﹤0.01% |
16,940
+80
| +0.5% | +$1.35K |
|
2291
PTC Therapeutics
PTCT
$4.84B
| $285K | ﹤0.01% |
8,076
-152
| -2% | -$5.36K |
|
|
NEX
2292
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $285K | ﹤0.01% |
25,860
-540
| -2% | -$5.95K |
|
2293
Olaplex Holdings
OLPX
$961M
| $283K | ﹤0.01% |
19,250
+8,879
| +86% | +$131K |
|
2294
Hayward Holdings
HAYW
$3.48B
| $282K | ﹤0.01% |
17,725
-506
| -3% | -$8.05K |
|
|
RETA
2295
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $281K | ﹤0.01% |
11,053
-73
| -0.7% | -$1.86K |
|
2296
Bioventus
BVS
$487M
| $279K | ﹤0.01% |
+23,208
| New | +$279K |
|
2297
Fulcrum Therapeutics
FULC
$378M
| $278K | ﹤0.01% |
+28,907
| New | +$278K |
|
2298
SES AI
SES
$424M
| $276K | ﹤0.01% |
+42,803
| New | +$276K |
|
2299
Revolve Group
RVLV
$1.71B
| $275K | ﹤0.01% |
6,498
-3,578
| -36% | -$151K |
|
2300
Avidity Biosciences
RNA
$5.28B
| $273K | ﹤0.01% |
19,093
-267
| -1% | -$3.82K |
|